From the patient to the population: Use of genomics for population screening
Authors:
Open Access
- 24 October 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 893832
Abstract
Genomic medicine is expanding from a focus on diagnosis at the patient level to prevention at the population level given the ongoing under-ascertainment of high-risk and actionable genetic conditions using current strategies, particularly hereditary breast and ovarian cancer (HBOC), Lynch Syndrome (LS) and familial hypercholesterolemia (FH). The availability of large-scale next-generation sequencing strategies and preventive options for these conditions makes it increasingly feasible to screen pre-symptomatic individuals through public health-based approaches, rather than restricting testing to high-risk groups. This raises anew, and with urgency, questions about the limits of screening as well as the moral authority and capacity to screen for genetic conditions at a population level. We aimed to answer some of these critical questions by using the WHO Wilson and Jungner criteria to guide a synthesis of current evidence on population genomic screening for HBOC, LS, and FH.Keywords
This publication has 275 references indexed in Scilit:
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialThe Lancet, 2011
- Annual screening strategies in BRCA1 and BRCA2 gene mutation carriersCancer, 2011
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- Risks of Lynch Syndrome Cancers for MSH6 Mutation CarriersJNCI: Journal of the National Cancer Institute, 2010
- Public and Biobank Participant Attitudes toward Genetic Research Participation and Data SharingPublic Health Genomics, 2010
- Grading quality of evidence and strength of recommendations in clinical practice guidelinesAllergy, 2009
- Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and managementMolecular Oncology, 2009
- The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working GroupGenetics in Medicine, 2009
- The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 MutationsGastroenterology, 2008
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996